These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27914600)

  • 21. Association of N-acetyltransferase-2 polymorphism with an increased risk of coronary heart disease in a Chinese population.
    Sun JD; Yuan H; Hu HQ; Yu HM
    Genet Mol Res; 2016 Mar; 15(1):15016954. PubMed ID: 26985933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)--an investigation in a department of surgical medicine.
    Farker K; Schotte U; Scheele J; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):387-91. PubMed ID: 12877350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus.
    von Schmiedeberg S; Fritsche E; Rönnau AC; Specker C; Golka K; Richter-Hintz D; Schuppe HC; Lehmann P; Ruzicka T; Esser C; Abel J; Gleichmann E
    Adv Exp Med Biol; 1999; 455():147-52. PubMed ID: 10599336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
    Ozbek YK; Oztürk T; Tüzüner BM; Calay Z; Ilvan S; Seyhan FM; Kisakesen HI; Oztürk O; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2885-9. PubMed ID: 20683028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.
    Borlak J; Reamon-Buettner SM
    BMC Med Genet; 2006 Mar; 7():30. PubMed ID: 16571112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
    Gupta VH; Amarapurkar DN; Singh M; Sasi P; Joshi JM; Baijal R; Ramegowda PH; Amarapurkar AD; Joshi K; Wangikar PP
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1368-74. PubMed ID: 23875638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid method of screening for N-acetyltransferase (NAT2) phenotype by use of the WAVE DNA fragment analysis system.
    Osborne A; Bell C; Grant F; Dick F; Seaton A; Haites N
    Biochem Genet; 2003 Dec; 41(11-12):405-11. PubMed ID: 14994828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The IL-16 gene polymorphisms and the risk of the systemic lupus erythematosus.
    Xue H; Gao L; Wu Y; Fang W; Wang L; Li C; Li Y; Liang W; Zhang L
    Clin Chim Acta; 2009 May; 403(1-2):223-5. PubMed ID: 19298795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].
    An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma].
    Lei D; Pan X; Guo C; Xu F; Zhang L; Liu D; Luan X
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):154-6. PubMed ID: 12015038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSTM1-null genotype as a risk factor for sporadic colorectal cancer in a Romanian population. Association with the NAT2-rapid-acetylator phenotype and exposure to environmental factors.
    Procopciuc LM; Osian G
    Cancer Invest; 2014 Feb; 32(2):53-62. PubMed ID: 24467372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
    Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
    J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia.
    Tebien EM; Khalil HB; Mills J; Elderdery AY
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3711-3717. PubMed ID: 33369472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population.
    Chelouti H; Khelil M
    Ann Hum Biol; 2017 Sep; 44(6):531-536. PubMed ID: 28347189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.
    Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.
    Doll MA; Fretland AJ; Deitz AC; Hein DW
    Anal Biochem; 1995 Nov; 231(2):413-20. PubMed ID: 8594994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-acetyltransferase 2 (NAT2) polymorphism in patients with atopic asthma.
    Pawlik A; Juzyszyn Z; Gawronska-Szklarz B
    Arch Med Res; 2009 May; 40(4):264-7. PubMed ID: 19608015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
    Liu HE; Hsiao PY; Lee CC; Lee JA; Chen HY
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):661-5. PubMed ID: 18349284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Functional Polymorphisms of DNA Double-Strand Breaks in Repair Genes XRCC5, XRCC6 and XRCC7 with the Risk of Systemic Lupus Erythematosus in South East Iran.
    Jahantigh D; Salimi S; Mousavi M; Moossavi M; Mohammadoo-Khorasani M; Narooei-nejad M; Sandoughi M
    DNA Cell Biol; 2015 May; 34(5):360-6. PubMed ID: 25756210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.